Literature DB >> 23290693

Camptodactyly-arthropathy-coxavara-pericarditis syndrome in Saudi Arabia: clinical and molecular genetic findings in 22 patients.

Intisar Albuhairan1, Sulaiman M Al-Mayouf.   

Abstract

BACKGROUND: Camptodactyly-arthropathy-coxavara-pericarditis (CACP) syndrome is a rare autosomal recessive disorder caused by mutations in the gene proteoglycan 4 (PRG4), affecting lubricin production, which is an essential protein for joint function. Manifestations vary between affected individuals with camptodactyly, early-onsetnon-inflammatory arthropathy, coxa vara deformity and non-inflammatory pericarditis.
OBJECTIVE: To describe the clinical, laboratory, radiological and genetic findings of CACP syndrome in children from Saudi Arabia.
METHODS: Medical records of all the children with CACP syndrome seen between June 1990 and June 2012 at King Faisal Specialist Hospital and Research Center, Riyadh were reviewed. The data include gender,age of first disease manifestations,referral diagnosis, clinical and radiological features, and molecular genetic studies as well as functional status at the last follow-upvisit.
RESULTS: Twenty-two patients (15 boys), (clinical and genetic data of 15 patients were previously published) with mean age at diagnosis 3.7 (1-14) years, were included in this cohort study. The referral diagnosis was inaccurate in all patients; juvenile idiopathic arthritis (JIA) was the referral diagnosis in majority of the patients. Six families had more than one affected child. Camptodactyly and large joints arthropathy were present in all the cases. Camptodactyly was observed in the neonatal period in all the patients, while other joint involvement was observed through the 1st year of life. All patients had a normal cardiac evaluation but two children had evidence of pericarditis. All patients had normal inflammatory markers and the result for rheumatoid factor test was negative. Radiological findings included coxa vara with a short femoral neck and flat, irregular femoral heads and intra-osseous cysts, increased joint space, and abnormal modeling of the acetabulum with small iliac wings. Other joints (knees, ankle, elbow and wrist) showed soft-tissue swelling consistent with thick cartilage and abnormal modeling with evidence of intra-articular fluid in majority of the patients. Synovial biopsy from three patients revealed proliferating synovial epithelium with moderate fibro-collagenous densities and multinucleated giant cells, occasional lymphocytes or neutrophils were identified. Previously, a locus responsible for causing CACP syndrome has been reported in eight patients of our cohort; it has been assigned to 1q25-q31. Furthermore, in seven newly diagnosed patients from four unrelated families, five novel mutations were found. All patients were referred to us while they were on NSAIDs, 10 patients used antirheumatic drugs (prednisone and methotrexate) and two patients were treated with etanercept. In all patients, treatment was ineffective apart from mild pain relief.
CONCLUSION: CACP syndrome is an autosomal recessive disorder occurring due to mutations in the gene PRG4 encoding lubricin; it is not an uncommon disorder in Saudi Arabia. Pericarditis is rarely seen in our patients. Our data suggest that CACP syndrome may be easily confused with JIA, causing a delay in diagnosis and probably unnecessary treatment with antirheumatic drugs including biologic agents.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Childhood arthropathy; Childhood rheumatic diseases; Contracture; Coxa vara; Familial arthropathy; Juvenile arthritis; Pediatrics; Saudi Arabia

Mesh:

Substances:

Year:  2013        PMID: 23290693     DOI: 10.1016/j.semarthrit.2012.11.004

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  7 in total

1.  CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort.

Authors:  Sara Ciullini Mannurita; Marina Vignoli; Lucia Bianchi; Anuela Kondi; Valeria Gerloni; Luciana Breda; Rebecca Ten Cate; Maria Alessio; Angelo Ravelli; Fernanda Falcini; Eleonora Gambineri
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

2.  Novel mutations in PRG4 gene in two Indian families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Rajashree S Nandagopalan; Shubha R Phadke; Ashwin B Dalal; Prajnya Ranganath
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

3.  The Efficacy of Yttrium-90 Radiosynovectomy in Patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome.

Authors:  Sulaiman Mohammed Al-Mayouf; Nora Almutairi; Khalid Alismail
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

4.  Quadruped Gait and Regulation of Apoptotic Factors in Tibiofemoral Joints following Intra-Articular rhPRG4 Injection in Prg4 Null Mice.

Authors:  Daniel S Yang; Edward E Dickerson; Ling X Zhang; Holly Richendrfer; Padmini N Karamchedu; Gary J Badger; Tannin A Schmidt; Alger M Fredericks; Khaled A Elsaid; Gregory D Jay
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

5.  Lubricin restoration in a mouse model of congenital deficiency.

Authors:  Adele Hill; Kimberly A Waller; Yajun Cui; Justin M Allen; Patrick Smits; Ling X Zhang; Ugur M Ayturk; Steven Hann; Samantha G Lessard; David Zurakowski; Matthew L Warman; Gregory D Jay
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

6.  Protein-losing enteropathy in camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Bram Peters; Janneke H M Schuurs-Hoeijmakers; Joris Fuijkschot; Annette Reimer; Michiel van der Flier; Dorien Lugtenberg; Esther P A H Hoppenreijs
Journal:  Pediatr Rheumatol Online J       Date:  2016-05-25       Impact factor: 3.054

7.  Genotype-phenotype investigation of 35 patients from 11 unrelated families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Saliha Yilmaz; Dilek Uludağ Alkaya; Özgür Kasapçopur; Kenan Barut; Ekin S Akdemir; Cemre Celen; Mark W Youngblood; Katsuhito Yasuno; Kaya Bilguvar; Murat Günel; Beyhan Tüysüz
Journal:  Mol Genet Genomic Med       Date:  2018-02-04       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.